DCRI and Partners Awarded FDA Grant to Create Global Pediatric Clinical Trials Network

Tuesday, October 17, 2017
Daniel Benjamin, Jr., MD, MPH, PhD and Michael (Micky) Cohen-Wolkowiez, MD, PhD

The DCRI will serve as the coordinating center for the network, which will support pediatric clinical trials around the world.

The DCRI and its strategic partners have been awarded a grant from the U.S. Food and Drug Administration (FDA) to establish a coordinating center for a Global Pediatric Clinical Trials Network (G-PCTN). The G-PCTN will support efficient pediatric clinical trials worldwide by developing scientific and operational infrastructure, fostering collaborative networks, sharing knowledge, and engaging stakeholders. The principal investigators for this program will be Daniel Benjamin, Jr., MD, MPH, PhD (pictured left), and Michael (Micky) Cohen-Wolkowiez, MD, PhD (pictured right).

“Although we’ve made a lot of progress in recent years, pediatric trials are still hard to complete successfully. There are perennial challenges – enrolling patients, finding access to supporting infrastructure, navigating a complex regulatory environment – that affect everyone working to advance pediatric research, but they can be especially challenging for research sites that don’t have access to resources or experience,” said Benjamin. “We’ve had great success with the Exclusivity Program, and NICHD’s off-patent program; but we need to work through some of the challenges that folks have had in meeting the requirements outlined by the Pediatric Research Equity Act. It’s crucial to have success across new therapeutics for children.”

Read Full DCRI article here.